View The Document

Accession Number:

AD1064653

Title:

Tesamorelin Therapy to Enhance Axonal Regeneration, Minimize Muscle Atrophy and Improve Functional Outcomes Following Peripheral Nerve Injury and Repair

Author(s):

• Tuffaha, Sami
• Shores, Jaimie T.
• Elhelali, Ala
• Lee, W. P.
• Ahlawat, Shivani
• Salvatori, Roberto

Author Organization(s):

• Johns Hopkins University

Report Date:

2018-10-01

Abstract:

We have hired and trained all necessary staff. We have received HRPO approval. We obtained IRB approval and continued review approval from JHU IRB and also IRB waivers from our primary recruitment sites (Union Memorial Hospital and University of Maryland Medical Center/ShockTrauma. The placebo purchase agreement and material transfer agreement have been agreed on and signed by JHU and Thera technologies responsible officials. We have enrolled and screened our first patient to the trial.

Document Type:

Conference:

Journal:

Pages:

13

File Size:

0.27MB

Contracts:

Grants:

Descriptors:

• peripheral nervous system
• biomedical research
• maryland
• pituitary and hypothalamic hormones and analogues
• therapy
• universities
• department of defense
• information operations
• agreements
• availability
• classification
• contracts
• health services
• hospitals
• instructions
• integrals
• materials
• monitoring
• security
• governments

Identifiers:

• study set-up phase
• patient recruitment
• tesamorelin
• peripheral nerve injury
• peripheral nerve regeneration
• Phase 2 clinical trial
• motor recovery
• sensory recovery
• ulnar nerve lacerations

SubjectCategory:

• Biological and Medical Sciences
• Biological and Medical Sciences

Distribution Statement:

Approved For Public Release

View The Document